video
<乌鸦传媒 class="article_title">
Shared Decision Making in Indolent Systemic Mastocytosis
With no curative therapies available, treatment for indolent systemic mastocytosis comes down to addressing symptoms, explains Sudipto Mukherjee, MD, PhD, MPH, of Cleveland Clinic. This begs the question: should patients with minimal symptoms be treated? (2:07)
<乌鸦传媒 class="article_title">
Indolent Systemic Mastocytosis and the Impact of Basophil Responsiveness
Abnormal activation of basophils occurs in patients with indolent systemic mastocytosis, with enhanced responsiveness to a chemotactic factor derived from bacteria. Here鈥檚 what this finding鈥攁nd others鈥攎ight imply for future treatments.
video
<乌鸦传媒 class="article_title">
Hypersensitivities in Indolent Systemic Mastocytosis
"It's a lived experience," says Sudipto Mukherjee, MD, PhD, MPH, of Cleveland Clinic. Nearly every patient with systemic mastocytosis will be sensitive to something, and it's often hard to predict. (2:39)
<乌鸦传媒 class="article_title">
What Drives Hypersensitivity Reactions in Mastocytosis?
An analysis of registry data concluded that hypersensitivity reactions in patients with mastocytosis are caused by exposure to certain triggers, including low tryptase levels and stings from certain insects. Here鈥檚 what else the team learned.
<乌鸦传媒 class="article_title">
In Systemic Mastocytosis, What鈥檚 the Impact of Type I Interferon Autoantibodies?
Investigators from the National Institutes of Health recently tackled the challenge of determining whether autoantibodies to type I interferon detected in the serum of patients with systemic mastocytosis are markers of disease severity.
<乌鸦传媒 class="article_title">
Systemic Mastocytosis Screening: Get Standardized
Investigators from Walter Reed Military Medical Center assessed the impact of a standardized screening protocol for systemic mastocytosis.
<乌鸦传媒 class="article_title">
Indolent or Advanced Systemic Mastocytosis? Plasma Protein Profiling May Help
These findings suggest that analyzing a panel of proteins in the blood could help differentiate between indolent and advanced forms of systemic mastocytosis, potentially leading to more precise diagnoses and personalized treatment.
